Full coverage· Tech· Updated
Israeli Startup Phantom GI Raises $5 Million for Minimally Invasive Bowel Stoma Device
Israeli startup Phantom GI has raised $5 million to develop a device that creates a bowel stoma through a single puncture without surgery or general anesthesia.
2 newsrooms · 2 languages · since
Plus
What happened
- 01Phantom GI raised $5 million to develop a minimally invasive stoma device.
- 02The device creates a bowel opening via a single skin puncture, avoiding surgery and general anesthesia.
- 03The technology is based on a technique developed by surgeon Dr. Eran Shlomovitz for a critically ill patient.
- 04An estimated 50,000 U.S. patients annually with bowel obstructions are too ill for conventional surgery.
- 05Phantom GI plans clinical trials in Canada starting early 2027, aiming for FDA approval.
- 06The device could eliminate the need for a second surgery to close a stoma.
Founded by surgeons Eran Shlomovitz and Eliyahu Bechor, and CEO Ido Sadan, the company aims to provide a less invasive option for patients with bowel obstructions. The device is in preclinical trials, with human studies planned for early 2027 in Canada, followed by FDA approval efforts. This technology could significantly reduce treatment complexity and expand patient access.
Haaretz English publishes in English. The key points are summarized above. Read Haaretz English’s full report from the link below.
The coverage
2 newsrooms on this story
Who covered it
- Left1
- CentreNone
- RightNone
- HarediNone
- ArabNone
- Other1